Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of AT1 Receptor in Peripheral Vascular Function
NCT00001628Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jul 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of losartan in atherosclerosis, heart failure (HF), hypertension (HTN) and 1 more (2 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Peripheral endothelial function. Started Jul 1997; status: completed.
02
Drugs
losartan
03
Conditions
atherosclerosisheart failure (HF)hypertension (HTN)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00001628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001628.